EyeCon 2026 Banner
|Articles|January 15, 2005

FDA approval of AMD treatment considered 'a milestone'

On Dec. 17, Eyetech Pharmaceuticals (EYET) announced FDA approval of pegaptanib sodium injection (Macugen) for the treatment of neovascular ("wet") age-related macular degeneration (AMD).


Latest CME